Here are three notes:
1. The PediFETCh — Pediatric FEcal microbial Transplant for Ulcerative Colitis — trial is a randomized clinical trial assessing fecal microbial transplant in children with ulcerative colitis.
2. The first pediatric patient in the trial has started receiving treatment.
3. The FMT procedure performed within the trial is based on RBX2660, Rebiotix’s lead drug platform for microbial restoration therapy.
More articles on GI/endoscopy:
Carving out a leadership role in GI: 7 gastroenterologists on taking charge in their field
3 GI physicians in the news – Dec. 18, 2015
‘A long time ago in a galaxy far, far away’: Star Wars music improves colonoscopy effectiveness
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
